#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile psoriatic arthritis Neonatal alloimmune thrombocytopenia Crohn's disease Alternating hemiplegia of childhood Primary biliary cholangitis Marginal zone lymphoma refractory Congenital myopathy Encephalopathy neonatal Factor VIII deficiency Alpha-1 antitrypsin deficiency Duchenne muscular dystrophy Iron overload Myelofibrosis Desmoplastic small round cell tumour Chronic graft versus host disease in liver More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Treatment Haemophagocytic lymphohistiocytosis – Basic Information Niemann-Pick disease – Life with Disease Glycogen storage disease type II – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Breast angiosarcoma metastatic – Life with Disease Progressive supranuclear palsy – Diagnostics Aicardi-Goutieres syndrome – Basic Information Shprintzen-Goldberg syndrome – Life with Disease Atypical haemolytic uraemic syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Perampanel Cladribine Carbamazepine (Ph. Eur.) Mitomycin S095035 THEOPHYLLINE ANHYDROUS WEF-001 Iopamidol Sar441566 Latanoprost Palonosetron TETRODOTOXIN ILOPROST Linagliptin Arbaclofen Calcium Levofolinate Tecaginlimab Carbamazepine Diacerein Haloperidol Decanoate More therapies…

    Learn about Your Condition

    Pancreatic fistula Fatty acid oxidation disorder Progressive multiple sclerosis Anal squamous cell carcinoma Open angle glaucoma Hepatotoxicity Wolfram syndrome Bartonellosis Biliary cancer metastatic Synovial sarcoma metastatic Post procedural swelling Appendicitis perforated Krabbe's disease Peripheral ischaemia Peripheral artery thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Dostarlimab Immunotherapy for Patients with Localized Gastric Cancer with Deficient Mismatch Repair or High Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    Investigated Drugs:
    • Dostarlimab
    France Italy

  • Study on Anastrozole, Letrozole, Exemestane, and Tamoxifen for Women Aged 70+ with Early Stage Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Tamoxifen
    • Anastrozole
    • Letrozole
    Italy

  • Study on Lutetium (177Lu) Vipivotide Tetraxetan to Delay Recurrence in Adult Men with PSMA-Positive Oligometastatic Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Piflufolastat (18F)
    • Lutetium (177Lu) Vipivotide Tetraxetan
    • Gozetotide
    Austria Belgium Czechia France Germany Greece +5

  • Study on the Effectiveness and Safety of Tislelizumab for Patients with Newly Diagnosed Hodgkin Lymphoma Who Cannot Have Standard Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Tislelizumab
    Italy

  • Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

    Recruiting

    3 1
    Investigated Diseases:
    • Hepatic fibrosis
    Investigated Drugs:
    • Efruxifermin
    France Germany Italy Poland Spain

  • Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anhydrous Caffeine
    • Camphor
    • Dapirolizumab Pegol
    Belgium Denmark France Germany Greece Italy +3

  • Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anhydrous Caffeine
    • Camphor
    • Dapirolizumab Pegol
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Amlitelimab
    Bulgaria Czechia Denmark France Germany Greece +7

  • Study on Trastuzumab Deruxtecan and Fluorouracil for Patients with HER2-Positive Gastric or Gastroesophageal Cancer with Minimal Residual Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Gastric cancer
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Calcium Folinate
    • Capecitabine
    Italy

  • Study on Preventing Crohn’s Disease Recurrence After Surgery Using Risankizumab and Drug Combination in Adults at Risk

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Guselkumab
    • Risankizumab
    Belgium Italy
Previous Page
1 … 25 26 27 28 29 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!